State Of Wyoming Autolus Therapeutics PLC Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.64 - $3.21 $147 - $288	90 Added 42.86%	300 $0
Q1 2023 May 12, 2023	SELL	$1.75 - $2.25 $14 - $18	-8 Reduced 3.67%	210 $0
Q4 2022 Feb 14, 2023	BUY	$1.74 - $3.27 $290 - $546	167 Added 327.45%	218 $0
Q3 2022 Nov 14, 2022	BUY	$2.04 - $3.76 $104 - $191	51 New	51 $0
Q2 2021 Feb 11, 2022	BUY	$4.78 - $7.96 $186 - $310	39 New	39 $0

104

163M

2.8K

13.4K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $208M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.